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1. Introduction
   Solid lipid nanoparticle introduced in 1991 represent an 
alternative carrier system to traditional colloidal carriers 
such as emulsions, liposomes and polymeric micro and 
nanoparticles[1]. Solid lipid nanoparticles are sub-micron 
colloidal carriers ranging from 50 to 1 000 nm, composed 
of physiological lipids and dispersed in aqueous surfactant 
solution. Solid lipid nanoparticles offers unique properties 
such as small size, large surface area, high drug loading 
and the interaction of phases at the interface and are 
attractive for their potential to improve performance of 
pharmaceuticals. In order to overcome the disadvantages 
associated with the liquid state of the oil droplets, the 
liquid lipid was replaced by a solid lipid, which eventually 
transformed in to solid lipid nanoparticles[2].
   Solid lipid nanoparticles are at the fore-front of the 
rapidly developing field of nanotechnology with several 
potential applications in drug delivery, clinical medicine 
and research as well as in other allied sciences. They are 
manufactured from synthetic/natural lipids and ideally 
suited to optimize drug delivery and reduce toxicity[3].
   Colloidal carriers are one of the approaches for the 
controlled delivery of drugs via dermal route and maintain 
the controlled release of active substances and targeting 
to skin layers. In monodispersed systems, solid lipid 
nanoparticles are the new generation of nanoparticulated 
active substance carriers and are attracting major attention 
as novel colloidal drug carriers for topical use[4].
   Neem oil is expressed from the seed of the Azadirachta 
indica tree. The tree is part of the Mahogany family 
Meliaceae and it is one of two species in the genus 
Azadirachta ,  native to India, Srilanka, Malaysia, 
Bangladesh and Pakistan. In Indian tradition Neem is one 
of the most important herbal ingredients which not only 
helps in fighting certain health problems, but also used 
in the earliest cosmetics and skin care products. Neem oil 
is used in the treatment of acne and pimples as well as 
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improves skin elasticity. The Neem oil normally contains 
oleic acid (52.8%), stearic acid (21.4%), palmitic acid 
(12.6%), linoleic acid (2.1%), and lower fatty acids (2.3%)[5]. 
   Acne is caused by bacteria named Propionibacterium 
acne (P. acne). The P. acne bacteria live deep within 
follicles and pores, away from the surface of the skin. In 
these follicles, P. acne bacteria use sebum, cellular debris 
and metabolic by-products from the surrounding skin 
tissue as their primary sources of energy and nutrients. 
Elevated production of sebum by hyperactive sebaceous 
glands or blockage of the follicle can cause P. acne 
bacteria to grow and multiply[6].
   All components of the Neem oil are strongly anti-
bacterial such as Margolone and Mahmoodin which can 
be used to kill bacteria P. acne. And not just that, Neem 
oil also contains salicylic acid like substances that 
reduce redness and inflammation. Neem contains active 
ingredients that are very similar to the ingredients in 
common medical acne treatment products[7]. In this present 
research, we investigated solid lipid nanoparticle loaded 
Neem oil for treatment of Acne. 
2. Materials and methods
   Soya lecithin was purchased from Yarrow chem products, 
Mumbai, India. Neem oil purchased from local market, 
PVA, Tween 80 and Dichloro methane were purchased from 
Finar chemicals, Ahmedabad India and all other chemicals 
used were of analytical grade.
2.1. Method of preparation of solid lipid nanoparticle 
loaded Neem oils
   Solid lipid nanoparticle of Neem oil was prepared by w/o/
w type double emulsification method[8]. Required quantity 
of Neem oil was dispersed in aqueous mixture of methanol 
(75% v/v) and required quantity of Lecithin & Cholesterol 
was dissolved in dichloromethane. The Neem oil solution 
was added slowly to lipid mixture and homogenized for 
15 min at 15 000 rpm in ultra probe sonicator (Orchid 
scientific, India) to produced white cloudy primary 
emulsion. The resultant primary emulsion was poured in to 
2% w/v of PVA solution and homogenized for additional 10 
min at 15 000 rpm. The resultant w/o/w type emulsion was 
stored at room temperature. The solvent was evaporated in 
Rota evaporator at 45 曟. The stable emulsion was freeze 
dried at -20 曟 under reduced pressure to get dried powder 
of solid lipid nanoparticles.
2.2. Drug polymer compatibility 
   The samples of pure Neem oil and mixture of Neem oil 
with lipids were mixed with 100 mg of potassium Bromide 
(KBr). The samples were compressed to disc by applying 
pressure of 5 tons for 3 min in a hydraulic press. The 
prepared pellets were placed in the sample cell and the 
spectrums were analysed in the region of 4 000-400 cm-1. 
By comparing the spectrums of pure Neem oil and Neem 
oil with lipids, the compatibility study was performed[9].
2.3. Surface morphology
   Surface morphology of solid lipid nanoparticles loaded 
Neem oil was observed by Scanning electron microscope 
(SEM). A small amount of SLN was taken in metal stub. 
The stub was coated with conductive gold by Hitachi 1010 
ion sputter and observed under Hitachi 3000 N Scanning 
electron microscope (JSM 5610 LV SEM, JEOL, Japan) 
chamber. The image was scanned at an acceleration 
voltage of 20 kV with a chamber pressure of 0.8 mmHg[10].
2.4. Particle size analysis 
   Particle size of nanoparticles was determined using 
Malvern particle size analyzer (Zetasizer 4000S, Japan). 
For particle size analysis[11], solid lipid nanoparticles were 
suspended in double distilled water and one drop was 
placed on clean slide and the particle size was observed. 
The average particle size was calculated and significant 
value (P<0.05) was calculated by using Graph pad prism 
5.1 software.
2.5. Polydispersity index
   Poly dispersity index value was used to characterize the 
monodispersed and polydispersed nature of nanoparticles. 
Higher the Polydispersity index values indicate the high 
level of non uniformity. 
2.6. Quantification of drug entrapment efficiency
   The entrapment efficiency was calculated by using 
100 mg of solid lipid nanoparticles dissolved in 20 mL of 
dichloromethane and the solution was centrifuged at 12 
000 rpm. The supernated fluid was collected and passed 
through membrane filter. The quantity of drug in the 
solution was measured by ultra violet spectroscopy at 263 
nm[12].
  Drug entrapment (%) = Quantity of drug in nanoparticle/
Mass of drug in the formulation×100
2.7. In-vitro release study 
   In-vitro release of solid lipid nanoparticles loaded Neem 
oil was carried out by using modified Franz diffusion 
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apparatus[13]. About 10 mg Neem oil equivalent solid 
lipid nanoparticles were placed in donor compartment 
containing phosphate buffer (pH 7.4) at (37依2) 曟. Drug 
release was assessed by intermittently sampling the 
receptor medium (5 mL) and fresh phosphate buffer saline 
solution was replaced. The samples were filtered in 
membrane filter (0.22 毺m) and the amount of drug released 
was quantified by a U.V. Spectrophotometer at 263 nm.
2.8. Stability studies
   For evaluation of stability selected formulation (F4) 
containing 10:1 ratio of Lecithin & Cholesterol was stored 
at 5 曟, 45 曟 and room temperature for 3 weeks. The 
entrapment efficiency and particles size measurement were 
evaluated after storage period of 3 week at 5 曟 and 45 曟 
and room temperature in the dark condition[14].
3. Results
3.1. Preparation of solid lipid nanoparticles
   In the present study, the effect of concentration of lipid 
mixture (lecithin: cholesterol) and surfactant on preparation 
of Neem oil loaded solid lipid nanoparticles were 
evaluated. In these preparations, lecithin and cholesterol 
were used as lipid and Tween 80 as surfactant. SLNs loaded 
Neem oil was prepared by double emulsification (w/o/w) 
using high speed ultra probe sonicator. The aqueous phase 
of methanolic solution containing Neem oil was poured 
to organic phase containing lipid at high homogenization 
speed of 15 000 rpm for 15 min with addition of Tween 
80. The Tween 80 solution reduced the interfacial tension 
between the phases. The uniform size globules were 
formed as w/o type emulsion. This emulsion was further 
homogenised with 2% w/v PVA solution as co-surfactant 
to form double emulsion (w/o/w). The formed emulsion 
was stabilized and stability was maintained by hardening 
properties of co-emulsifier. The solid lipid nanoparticles 
were prepared by using increasing concentration of lipid 
and surfactant. 
Table 1. 
Formulation of Neem oil loaded solid lipid nanoparticles.
S. no Ingredients F1 F2 F3 F4
1 Neem oil   1 mL   1 mL   1 mL 1 mL
2 Lecithin 10 mg 20 mg 50 mg 100 mg
3 Cholesterol 10 mg 10 mg 10 mg   10 mg
4 Dichloromethane 10 mL 10 mL 10 mL   10 mL
5. Tween 80 1% 2% 3%  4%
6. PVA 2% 2% 2%  2%
7. Water q.s q.s q.s q.s
3.2. Drug polymer compatibility
   FT-IR spectrum of pure drug and mixture of drug and 
lipid are shown in Figure 1. Form the spectral study it was 
observed that there was no significant change in the peaks 
of pure drug and drug lipid mixture. Hence, no specific 
interaction was observed between the drug and the lipid 
used in the formulations.
3.3. Effect of lipid concentration on entrapment efficiency
   The Solid lipid nanoparticles were prepared by different 
proportions of Cholesterol and Lecithin (1:1, 1:2, 1:5 and 
1:10). The entrapment efficiency of Solid lipid nanoparticle 
loaded Neem oil increases with increase in concentration 
of soya lecithin and Tween 80. The entrapment efficiency 
was in the range between 67.23%-82.10% as shown in Table 
2. The entrapment efficiency (%) was directly proportional 
to concentration of Lecithin and cholesterol. Normally low 
entrapment efficiency was observed at low affinity between 
drug at different solvent (organic and aqueous). The F4 
formulation of SLN has showed maximum entrapment 
(82.1%).
Figure 1. Drug polymer compatibility.
Table 2.
Evaluation of solid lipid nanoparticles.
S.no. 
Batch 
code
Particlesize 
(nm)
Morphology
Entrapment 
efficiency (%)
PDI
1 F1 867.5依4.7 Spherical 67.23依8.50 0.461依0.200
2 F2 923.9依2.8 Spherical 71.64依4.80 0.432依0.200
3 F3 746.4依6.2 Spherical 77.98依9.40 0.402依0.800
4 F4 221.6依4.1 Spherical 82.10依4.50 0.948依0.400
PDI: Poly dispersity index (The data were analyzed by two-way 
analysis of variance with students t test and represented as mean 依 SD 
(n=3) using Graph pad prism 2.1 software. Statistical differences were 
observed at (P≤0.05). 
3.4. Particle size and poly dispersity index
   The Solid lipid nanoparticles loaded Neem oil (F1-F4) 
formulations were observed to be spherical shape with 
smooth surface. The particle size of all the formulations 
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(F1-F4) showed between 421.6-867.5 nm as shown in 
Table 2. The particle size of solid lipid nanoparticles was 
mainly affected by homogenization speed and saturated 
lipid concentration. During homogenization of SLN the 
aggregation was reduced by reducing interfacial tension 
and stabilised spherical shape particles were formed by 
addition of tween 80. On increasing the concentration 
of surfactant, mean particle size of SLNs was reduced. 
The organic solvent used in these formulations rapidly 
partitioned into the continuous aqueous medium and the 
lipid precipitated around the drug. The simultaneous 
evaporation of the entrapped solvent lead to the formation 
of spherical shaped solid lipid nanoparticles.
   The dispersity index of Solid lipid nanoparticles loaded 
Neem oil were in range between 0.40-0.46 as shown in 
Table 2. The PDI was reduced to narrow range due to 
increasing concentration surfactant.  
Figure 2. SEM image of SLN loaded Neem oil.
3.5. In vitro release studies
   The in vitro release studies of Solid lipid nanoparticles 
loaded Neem oil at different lecithin concentrations were 
evaluated by modified Franz diffusion cell. The amounts 
of drug release of all formulations (F1-F4) were showed in 
Figure 3. The solid lipid nanoparticles show initial burst 
release (30 min) of 3.56%-30.05%. 
   The F4 formulation showed less drug release due to 
high polymeric matrix. At end of 12 h, limited percentage 
of drug release was observed around 52.54%. The F4 
formulations showed significantly less drug release over 
other formulations which clearly indicated that they can 
provide satisfied result for acne treatment over prolonged 
period of time.
Table 3.
Stability studies of selected formulation.
S.no. Parameters Fresh particles 0 曟 25 曟 45 曟
1 Particle size (nm) 221.6 245.7 221.0 239.0
2. Entrapment efficiency (%)   82.1   82.2   82.0   79.1
Stability studies data were showed after 3rd week.
   In order to determine drug release pattern of Solid lipid 
nanoparticle loaded Neem oils, the release data were 
substituted to zero, first, higuchi, korsemeyer peppas 
models. The release constant and regression co-efficient 
(R2) was calculated from slopes of appropriate plots. The 
solid lipid nanoparticles loaded Neem oil were best fitted 
by zero order release [R2=0.949 7-0.974 5] followed by 
higuchi equation [R2=0.967 2-0.990 3]. 
   The drug release kinetics demonstrates that release 
was independent of concentration. For explaining 
the mechanism of drug release from nanoparticles, 
korsemeyer peppas equation showed good linearity and 
the release exponent n=0.234 3-0.812 0. This appears to 
be the coupling of diffusion and erosion mechanism i.e. 
anomalous diffusion.
Figure 3. In vitro drug release studies.
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3.6. Stability studies
   During the period of storage, the formulation showed 
no change in colour, creaming and phase separation. The 
particle size increased significantly, after storage of 3 
weeks at 45 曟. But there was no significant increase in 
particle size of SLN stored at 5 曟 and 25 曟 after 3 weeks. 
   The entrapment efficiency was reduced at higher 
temperature (45 曟) than other storage conditions. When the 
particles were aggregated, drug molecule was leaked out 
from lipid matrix. 
   The solid lipid nanoparticles loaded Neem oil could 
successfully deliver the action on acne site with out 
penetration on to blood stream.
4. Discussion
   The Neem oil loaded solid lipid nanoparticles were 
prepared by double emulsification technique. The Tween 
80 solution reduced the interfacial tension between the 
phases. The uniform size globules were formed as w/o type 
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emulsion. The formed emulsion was stabilized and stability 
was maintained by hardening properties of co-emulsifier 
(PVA). The solid lipid nanoparticles were prepared by 
using increasing concentration of lipid and surfactant. The 
FTIR spectrums reveal that drug incompatibles with lipids. 
The entrapment efficiency (%) was directly proportional 
to concentration of Lecithin and cholesterol. Normally 
low entrapment efficiency was observed at low affinity 
of drug between the solvents (organic and aqueous). The 
F4 formulation of SLN has showed maximum entrapment 
(82.1%) due to high affinity of drug with lipid matrix.
   During homogenization of SLN, the aggregation was 
reduced by reducing interfacial tension and stabilized 
spherical shape particles were formed by addition of 
Tween 80. On increasing the concentration of surfactant, 
mean particle size of SLNs was reduced. 
   The organic solvent used in these formulations rapidly 
partitioned into the continuous aqueous medium and the 
lipid precipitated around the drug. The simultaneous 
evaporation of the entrapped solvent lead to the formation 
of spherical shaped solid lipid nanoparticles. From the four 
formulations, F4 showed significantly less drug release 
over other formulations which clearly indicated that 
they can provide satisfied result for acne treatment over 
prolonged period of time. 
   The drug release characters were confirmed by following 
zero order release with higuchi model. The formulation 
F4 showed korsemeyer peppas values of n=0.234 3-0.812, 
which reveals that drug release in the mechanism 
of coupling of diffusion and erosion i.e. anomalous 
diffusion. The optimized formulation showed stability at 
room temperature and 5 曟 but at 45 曟, particles were 
aggregated, drug molecule was leaked out from lipid 
matrix. 
   It was assumed that the high temperature (45 曟) increased 
the kinetic energy of system, which could accelerate the 
collision of particles which consequently increase the 
possibility of aggregation.
  In this study the potential of SLNs dispersions as 
carriers for delivery of Neem oil was exploited. Solid lipid 
Nanoparticles were prepared by the w/o/w type double 
emulsification method by using bio-acceptable lipids such 
as Cholesterol and Lecithin and tween 80 as emulsifier. 
Drug loaded SLNs showed average diameters in the narrow 
colloidal size range, a good loading capacity and drug 
release. Results strongly support the potential application 
of SLNs as drug delivery system in acne treatment.
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